Artiva Biotherapeutics
We are dedicated to making safe and effective cell therapies accessible to any cancer patient who may benefit.
88 employees · est. 2019 · San Diego, United States
Nkarta, Inc.
A New Way Forward for Autoimmune Disease
157 employees · est. 2015 · South San Francisco, United...
Nkarta, Inc. is the older company (2019 vs 2015).
1 signal in the last 90 days
Side-by-Side Comparison
| Metric | Artiva Biotherapeutics | Nkarta, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2019 | 2015 older |
| Headquarters | ||
| Headquarters | San Diego, United States | South San Francisco, United States |
| Employees | ||
| Employees | 88 | 157 |
| Industry | ||
| Industry | Biotechnology, Health and Wellness, Life Sciences | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Series B | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $198.00M | $595.00M |
| Funding Rounds | ||
| Funding Rounds | 2 | 4 |
| Services | ||
| Services | Not tracked yet | Development of immunotherapy drugs, Conducting clinical trials, Research and development of NK cell technology |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with autoimmune diseases, Healthcare providers, Medical researchers |
| Taxonomy | ||
| Taxonomy | Immunotherapy, Cell Therapy, NK Cell Therapy, Allogeneic Therapy, Clinical Trials, Cancer Treatment, Autoimmune Diseases, Monoclonal Antibodies, Lupus Nephritis, Non-Hodgkin Lymphoma, CD30-positive Lymphomas, Innovation, Biomedical Research | Allogeneic NK Cells, Cell Therapy, Immuno-Oncology, Tumor Targeting, Cell Engineering, Cryopreservation, Cell Expansion, Hematologic Malignancies, Solid Tumor Malignancies, Therapy Manufacturing, Cancer Research, Natural Killer Cells, Oncology Therapeutics, Autoimmune Disease Treatment |
| Website | ||
| Website | artivabio.com | nkartatx.com |
About Artiva Biotherapeutics
Artiva Biotherapeutics is a biotechnology company founded in 2019 with a mission to make safe and effective cell therapies accessible to any cancer patient who may benefit. The company specializes in producing off-the-shelf, allogeneic NK cell therapies at a massive scale. Its lead program, AlloNK®,...
About Nkarta, Inc.
Nkarta, Inc., founded in 2015, is at the forefront of innovative biotechnology solutions aimed at tackling autoimmune diseases. Their slogan, "A New Way Forward for Autoimmune Disease", reflects their pioneering approach in the Biotechnology and Health Care sectors. The company specializes in devel...
We will tell you when either one moves
BounceWatch watches Artiva Biotherapeutics and Nkarta, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Artiva Biotherapeutics and Nkarta, Inc. — by email.
Frequently Asked Questions
Compare Artiva Biotherapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Artiva Biotherapeutics on 11 Sep 2024, and Nkarta, Inc. on 22 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
